In response to a challenge from the Council for Responsible Nutrition, the National Advertising Division (NAD) recommended that Nature’s Boost discontinue health claims concerning the ability of its Blood Boost Formula dietary supplement to cure diabetes and substantially reduce a ...
On June 5, 2020, the Federal Trade Commission (FTC) sent six warning letters to multilevel marketing companies to stop making claims about their products’ ability to treat or prevent COVID-19 and about the earnings that people who have recently lost income can make.
In April, the Internal Revenue Service (IRS) provided relief regarding certain filing, payment, and other time-sensitive action deadlines in the wake of the COVID-19 pandemic.
Just over three months after Governor Newsom issued California’s Stay at Home Order to combat the spread of COVID-19, almost all of the state’s 58 counties have moved to reopen most of their businesses and public sectors.
Drug manufacturers should immediately evaluate whether they have been correctly classifying their products in data submitted to the Medicaid Drug Rebate Program (MDRP) to minimize penalties they could face for any errors.
Last week, several additional sectors reopened in Los Angeles County, pursuant to state guidance for variance.
Los Angeles County continues to move forward in reopening key economic and community sectors that were previously closed or operating in limited capacity due to the COVID-19 pandemic.
As set forth in the CARES Act, a substantial portion of monies borrowed under the Paycheck Protection Program (PPP) may be eligible for forgiveness.
The Federal Communications Commission (FCC) has approved its 11th set of COVID-19 telehealth program applications, totaling $23.25 million for 62 providers.
The New York State Department of Health (DOH) recently issued guidance on the new Certificate of Need (CON) licensure process for freestanding midwifery birth centers (also, MBCs).